Literature DB >> 9614961

[Economic analysis of adjuvant interferon-alpha-2-therapy in high risk melanoma patients based on results of the ECOG 1684 Study Group].

W Hoffmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9614961     DOI： 10.1007/bf03038725

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  3 in total

1.  Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684.

Authors:  B E Hillner; J M Kirkwood; M B Atkins; E R Johnson; T J Smith
Journal:  J Clin Oncol       Date:  1997-06       Impact factor: 44.544

2.  Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model.

Authors:  B E Hillner; T J Smith
Journal:  N Engl J Med       Date:  1991-01-17       Impact factor: 91.245

3.  Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Authors:  J M Kirkwood; M H Strawderman; M S Ernstoff; T J Smith; E C Borden; R H Blum
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.